Clinicians need to be careful when considering rivaroxaban use in patients with this autoimmune disorder, one expert says.

An expanded analysis from ALERTS found that 77% of silent-MI patients presented within 2 hours of the alarm going off.

The new indication covers VTE prophylaxis in acutely ill patients at risk for thromboembolic events without a high bleeding risk.

(UPDATED) Investigators have long said the death/MI reduction with CT angiography for chest pain makes sense. Here’s why, they say.

More women at risk were found, but they remained undertreated compared with men.

The results should not discourage women from being active on Twitter, especially in cardiology, one expert says.

(UPDATED) In young adults, CAD is particularly aggressive, tends to spread to other arteries, and worsens prognosis, say investigators.

Pedometers and accelerometers in people with cardiometabolic conditions can help improve physical activity as part of a bigger plan.

The risk of MI/CV death was similar regardless of whether the final diagnosis was type 1 MI, type 2 MI, or myocardial injury.

Whether the benefit is due to Impella itself or to the systematic, team-based approach remains to be seen.

The researchers say the real-world outcomes refute the findings of a hotly debated meta-analysis.

The new data add to the growing body of evidence tying various social factors with risk of incident CVD, say researchers.